Influence of Fe(II) and Fe(III) on the expression of genes related to cholesterol- and fatty acid metabolism in human vascular smooth muscle cells

Journal of Materials Science: Materials in Medicine

Volumn 21, Issue 5, 2010, Pages 1655-1663

  Drynda, Andreas ^a   Hoehn, René ^a   Peuster, Matthias ^b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY COMPONENTS; ANIMAL EXPERIMENTS; CARDIOVASCULAR DEVICES; COENZYME A; DESATURASE; DNA CHIP TECHNOLOGY; FATTY ACID METABOLISM; FERRIC IRON; FERROUS IRON; HIGH CONCENTRATION; HUMAN VASCULAR SMOOTH MUSCLE CELLS; IRON-BASED; LOW DENSITY LIPOPROTEINS; MECHANICAL FEATURE; METABOLIC ACTIVITY; REACTIVE OXYGEN SPECIES; REAL-TIME PCR; SOLID IRON; SYNTHASES; UP-REGULATION; VASCULAR SMOOTH MUSCLE CELLS;

ACIDS; BIOCHEMISTRY; BLOOD VESSEL PROSTHESES; CELLS; CHLORINE COMPOUNDS; CHOLESTEROL; FATTY ACIDS; GENE EXPRESSION; IRON; METABOLISM; MUSCLE; OXYGEN;

IRON COMPOUNDS;

ACYL COENZYME A DESATURASE 1; FERRIC ION; FERROUS GLUCONATE; FERROUS ION; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; FATTY ACID METABOLISM; GENE EXPRESSION; HUMAN; HUMAN CELL; MUSCLE CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ACYL COENZYME A; CHOLESTEROL; FATTY ACIDS; FERRIC COMPOUNDS; FERROUS COMPOUNDS; GENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA SYNTHASE; IRON; LIPID METABOLISM; LIPOPROTEINS, LDL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, LDL; UP-REGULATION;

ANIMALIA;

EID: 77954535213     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-010-4014-8     Document Type: Article

References (32)

1. Peuster M, Hesse C, Schloo T, Fink C, Beerbaum P, von Schnakenburg C. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials. 2006;27:4955-4962
2. Waksman R, Pakala R, Baffour R, Seabron R, Hellinga D, Tio FO. Short-term effects of biocorrodible iron stents in porcine coronary arteries. J Interv Cardiol. 2008;21:15-20.
3. Ramcharitar S, Serruys PW. Fully biodegradable coronary stents: progress to date. Am J Cardiovasc Drugs. 2008;8:305-314
4. Heintz C, Riepe G, Birken L, Kaiser E, ChakféN, Morlock M, et al. Corroded nitinol wires in explanted aortic endografts: an important mechanism of failure? J Endovasc Ther. 2001;8:248-253
5. Reclaru L, Lerf R, Eschler PY, Meyer JM. Corrosion behavior of a welded stainless-steel orthopedic implant. Biomaterials. 2001;22:269-279
6. Peuster M, Fink C, von Schnakenburg C, Hausdorf G. Dissolution of tungsten coils does not produce systemic toxicity, but leads to elevated levels of tungsten in the serum and recanalization of the previously occluded vessel. Cardiol Young. 2002;12:229-235
7. Ryan MP, Williams DE, Chater RJ, Hutton BM, McPhail DS. Why stainless steel corrodes. Nature. 2003;415:770-774
8. Brown DA, Lee EW, Loh CT, Kee ST. A new wave in treatment of vascular occlusive disease: biodegradable stents-clinical experience and scientific principles. J Vasc Interv Radiol. 2009;20:315-324
9. Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart. 2003;89:651-656
10. Drynda A, Hassel T, Hoehn R, Perz A, Bach FW, Peuster M. Development and biocompatibility of a novel corrodible fluoridecoated magnesium-calcium alloy with improved degradation kinetics and adequate mechanical properties for cardiovascular applications. J Biomed Mater Res A. 2009. Epub ahead of print.
11. Kraft CN, Diedrich O, Burian B, Schmitt O, Wimmer MA. Microvascular response of striated muscle to metal debris. A comparative in vivo study with titanium and stainless steel. J Bone Joint Surg Br. 2003;85:133-141
12. Peuster M, Wohlsein P, Brügmann M, Ehlerding M, Seidler K, Fink C, et al. A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6- 18 months after implantation into New Zealand white rabbits. Heart. 2001;86:563-569
13. Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341:1986-95. erratum in: N Engl J Med. 2000;342:364.
14. Mueller PP, May T, Perz A, Hauser H, Peuster M. Control of smooth muscle cell proliferation by ferrous iron. Biomaterials. 2006;27:2193-2200
15. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2746
16. Brown MS, Goldstein JL. Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc Natl Acad Sci USA. 1979;76:3330-3337
17. Vock C, Döring F, Nitz I. Transcriptional regulation of HMGCoA synthase and HMG-CoA reductase genes by human ACBP. Cell Physiol Biochem. 2008;22:515-524
18. Greenfeder S. Emerging strategies and agents to lower cardiovascular risk by increasing high density lipoprotein cholesterol levels. Curr Med Chem. 2009;16:144-156
19. Rokosz LL, Boulton DA, Butkiewicz EA, Sanyal G, Cueto MA, Lachance Pa, et al. Human cytoplasmic 3-hydroxy-3-methylglutaryl coenzyme A synthase: expression, purification, and characterization of recombinant wild-type and Cys129 mutant enzymes. Arch Biochem Biophys. 1994;312:1-13.
20. Martinelli N, Girelli D, Malerba G, Guarini P, Illig T, Trabetti E, et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr. 2008;88:941-949
21. Gotloib L, Silverberg D, Fudin R, Shostak A. Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron. J Nephrol. 2006;19:161-167
22. Farber JL. Mechanisms of cell injury by activated oxygen species. Environ Health Perspect. 1994;102(Suppl 10):17-24.
23. Marnett LJ. Oxy radicals, lipid peroxidation and DNA damage. Toxicology. 2002;181-182:219-222
24. Abdalla DS, Campa A, Monteiro HP. Low density lipoprotein oxidation by stimulated neutrophils and ferritin. Atherosclerosis. 1992;97:149-159
25. Enright HU, Miller WJ, Hebbel RP. Nucleosomal histone protein protects DNA from iron-mediated damage. Nucleic Acids Res. 1992;20:3341-3346
26. Bernotti S, Seidman E, Sinnett D, Brunet S, Dionne S, Delvin E, et al. Inflammatory reaction without endogenous antioxidant response in Caco-2 cells exposed to iron/ascorbate-mediated lipid peroxidation. Am J Physiol Gastrointest Liver Physiol. 2003;285: G898-906.
27. Suwalsky M, Martínez F, Cárdenas H, Grzyb J, Strzalka K. Iron affects the structure of cell membrane molecular models. Chem Phys Lipids. 2005;134:69-77.
28. http://pi.watson.com/data-stream.asp?product-group=1235&p=pi &language=E Watson Pharma, 09/2006.
29. Pai AB, Boyd AV, McQuade CR, Harford A, Norenberg JP, Zager PG. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. Pharmacotherapy. 2007;27:343-350
30. de Vecchi AF, Novembrino C, Lonati S, Ippolito S, Bamonti F. Two different modalities of iron gluconate i.v. administration: effects on iron, oxidative and inflammatory status in peritoneal dialysis patients. Nephrol Dial Transplant. 2007;22:1709-1713
31. Kolodgie FD, Burke AP, Nakazawa G, Cheng Q, Xu X, Virmani R. Free cholesterol in atherosclerotic plaques: where does it come from? Curr Opin Lipidol. 2007;18:500-507
32. Agostoni P, Vermeersch P, Knaapen M, Verheye S. Stent thrombosis is not always stent thrombosis: de novo atherosclerosis in a stented coronary segment. Int J Cardiol. 2009. Epub ahead of print.